$11.85
0.94% today
Nasdaq, Oct 03, 03:46 pm CET
ISIN
US03475V1017
Symbol
ANGO

AngioDynamics, Inc. Stock price

$11.74
+1.28 12.24% 1M
+0.88 8.10% 6M
+2.58 28.17% YTD
+4.09 53.46% 1Y
-8.67 42.48% 3Y
+0.25 2.13% 5Y
-1.42 10.79% 10Y
-8.52 42.05% 20Y
Nasdaq, Closing price Thu, Oct 02 2025
+0.67 6.05%

Key metrics

Basic
Market capitalization
$482.2m
Enterprise Value
$432.5m
Net debt
positive
Cash
$55.9m
Shares outstanding
41.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.6 | 1.5
EV/Sales
1.5 | 1.4
EV/FCF
negative
P/B
2.6
Financial Health
Equity Ratio
65.3%
Return on Equity
-18.6%
ROCE
-11.9%
ROIC
-13.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$292.5m | $313.3m
EBITDA
$-14.0m | $5.5m
EBIT
$-24.3m | $-30.2m
Net Income
$-34.0m | $-13.0m
Free Cash Flow
$-14.6m
Growth (TTM | estimate)
Revenue
-3.8% | 7.1%
EBITDA
33.9% | 138.9%
EBIT
29.0% | -24.1%
Net Income
81.6% | 61.9%
Free Cash Flow
57.0%
Margin (TTM | estimate)
Gross
53.9%
EBITDA
-4.8% | 1.7%
EBIT
-8.3%
Net
-11.6% | -4.1%
Free Cash Flow
-5.0%
More
EPS
$-0.8
FCF per Share
$-0.4
Short interest
9.7%
Employees
748
Rev per Employee
$390.0k
Show more

Is AngioDynamics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

AngioDynamics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a AngioDynamics, Inc. forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a AngioDynamics, Inc. forecast:

Buy
90%
Hold
10%

Financial data from AngioDynamics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
May '25
+/-
%
293 293
4% 4%
100%
- Direct Costs 135 135
10% 10%
46%
158 158
2% 2%
54%
- Selling and Administrative Expenses 145 145
1% 1%
50%
- Research and Development Expense 26 26
17% 17%
9%
-14 -14
34% 34%
-5%
- Depreciation and Amortization 10 10
21% 21%
4%
EBIT (Operating Income) EBIT -24 -24
29% 29%
-8%
Net Profit -34 -34
82% 82%
-12%

In millions USD.

Don't miss a Thing! We will send you all news about AngioDynamics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AngioDynamics, Inc. Stock News

Positive
Seeking Alpha
about 19 hours ago
AngioDynamics, Inc. remains a Buy, trading at a steep discount to peers despite double-digit MedTech growth and improving margins. ANGO's Med Tech division now drives 47% of sales, with strong performance from Auryon, AlphaVac, AngioVac, and NanoKnife products. Gross margin improved to 55.3%, operating costs are under control, and management expects positive cash flow and raised guidance for FY...
Positive
The Motley Fool
about 22 hours ago
AngioDynamics (ANGO 7.00%) stock soared 10.5% through 11:25 a.m. ET Thursday after beating on "earnings" (sort of) this morning.
Neutral
Seeking Alpha
one day ago
AngioDynamics, Inc. (NASDAQ:ANGO ) Q1 2026 Earnings Call October 2, 2025 8:00 AM EDT Company Participants James Clemmer - CEO, President & Director Stephen Trowbridge - Executive VP & CFO Conference Call Participants John Young - Canaccord Genuity Corp., Research Division Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Eduardo Martinez-Montes - H.C. Wainwright & Co, LLC, Re...
More AngioDynamics, Inc. News

Company Profile

AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.

Head office United States
CEO James Clemmer
Employees 748
Founded 1988
Website www.angiodynamics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today